Identifying FGF23 and PTH downstream regulators and mechanisms underlying hormone-induced phosphorylation will be critical for understanding disordered renal phosphate transport and mineral-ion metabolism associated with chronic kidney disease-mineral and bone disorder (CKD-MBD) and related phosphate-wasting disorders. Here, FGF23 is linked to bone disorder.